Menu
1. Once-weekly semaglutide in adults with overweight or obesity
2. Semaglutide
3. Liraglutide 3 mg (Saxenda®)
4. Inclusions - Exclusions
5. Methods
6. End points and assessments
7. Results
8. Clinical characteristics at Baseline
9. Results
10. Graphique
11. Semaglutide 2.4 mg (1x/sem, s.c.)
12. Adverse events
13. Discussion
14. Weight management for remission of type 2 Diabetes
15. Apparition d’ abus de substances après bypass gastrique (20-30 %)
16. Conclusion
17. merci à tous
18. Body composition
HUG FLASH Semaglutide, Pr Alain Golay, 18.05.21
Resources
Here are some useful links and documents:
Title
Title
Title
FINISH
SUBMIT
NEXT
PREV
Submit All